學術機構典藏
論文
期刊論文
|
期刊論文／Journal Paper (作者群，論文題目，期刊名稱，出版年月，卷號(期別):頁次起迄) |
日期 | |
| 1 | 董承昌(Cheng Chang Tung)、梁馨月(Hsin-Yueh Liang)、賴怡青(Yi-Ching Lai)、沈明毅(Ming-Yi Shen)、林圀宏(Kuo-Hung Lin)、張坤正(Kuan-Cheng Chang)、吳宏彬(Hung-Pin Wu)*，Early Experience of Patients with left Bundle Branch Block Corrected through Left Bundle Branch Area Pacing Compared with Conventional Right Ventricular Pacing: A Single-Center Retrospective Study，Acta Cardiologica Sinica，2023 May，39(39):394-405 | 2023 . 05 |
| 2 | (Simon Kraler)、(Florian A. Wenzl)、(Jody Vykoukal)、(Johannes F. Fahrmann)、沈明毅(Ming-Yi Shen)、陳得源(Der-Yuan Chen)、張坤正(Kuan-Cheng Chang)、張敬昆、(Arnold von Eckardstein)、(Lorenz Raber)、(Francois Mach)、(David Nanchen)、(Christian M. Matter)、(Luca Liberale)、(Giovanni G. Camici)、(Alexander Akhmedov)*、陳珠璜(Chu-Huang Chen)*、(Thomas F. Luscher)*，Low-density lipoprotein electronegativity and risk of death after acute coronary syndromes: A case-cohort analysis，ATHEROSCLEROSIS，2023 May，376(2023):43-52 | 2023 . 05 |
| 3 | 曾國峰(TSENG, KUO-FENG)、蔡秉宣(TSAI, PING-HSUAN)、王捷賢(Jie-Sian Wang)、陳芳玉、沈明毅(Ming-Yi Shen)*，Sesamol Attenuates Renal Inflammation and Arrests Reactive-Oxygen-Species-Mediated IL-1β Secretion via the HO-1-Induced Inhibition of the IKKα/NFκB Pathway In Vivo and In Vitro，Antioxidants，2022 Dec，11(12):2461 | 2022 . 12 |
| 4 | 王捷賢(Jie-Sian Wang)、姜秀穎(Hsiu-Yin Chiang)、王宇澄(Yu-Chen Wang)、葉宏傑(Hung-Chieh Yeh)、丁羿文(I-Wen Ting)、梁志嘉(Liang, Chih-Chia)、王牧群(Mu-Cyun Wang)、林則成(Che-Chen Lin)、蕭瓊子(Chiung-Tzu Hsiao)、沈明毅(Ming-Yi Shen)、郭錦輯(Kuo, Chin-Chi)*，Dyslipidemia and coronary artery calcium: From association to development of a risk-prediction nomogram，NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES，2022 Aug，32(8):1944-1954 | 2022 . 08 |
| 5 | 蔡秉宣(TSAI, PING-HSUAN)、(Li-Zhen Chen)、曾國峰(TSENG, KUO-FENG)、陳芳玉、沈明毅(Ming-Yi Shen)*，Apolipoprotein C3-Rich Low-Density Lipoprotein Induces Endothelial Cell Senescence via FBXO31 and Its Inhibition by Sesamol In Vitro and In Vivo，Biomedicines，2022 Apr，10():854 | 2022 . 04 |
| 6 | 王捷賢(Jie-Sian Wang)、蔡秉宣(TSAI, PING-HSUAN)、曾國峰(Tseng, Guo-Fong)、陳芳玉、(Wen-Chin Yang)、沈明毅(Ming-Yi Shen)*，Sesamol Ameliorates Renal Injury-Mediated Atherosclerosis Via Inhibition of Oxidative Stress/IKKα/p53，Antioxidants，2021 Sep，10():1519 | 2021 . 09 |
| 7 | 陳振聲、潘柏毅(Pan, Bo-Yi)、蔡秉宣(TSAI, PING-HSUAN)、陳芳玉、(Wen-Chin Yang)、沈明毅(Ming-Yi Shen)*，Kansuinine A Ameliorates Atherosclerosis and Human Aortic Endothelial Cell Apoptosis by Inhibiting Reactive Oxygen Species Production and Suppressing IKKβ/IκBα/NF-κB Signaling，INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES，2021 Sep，22():10309 | 2021 . 09 |
| 8 | (Meng-Ting Yang)、(Wei-Hung Chang)、(Tien-Fen Kuo)、沈明毅(Ming-Yi Shen)、(Chu-Wen Yang)、(Yin-Jing Tien)、(Bun-Yueh Lai)、(Yet-Ran Chen)、(Yi-Cheng Chang)、(Wen-Chin Yang)*，Identification of Novel Biomarkers for Pre-diabetic Diagnosis Using a Combinational Approach，Frontiers in Endocrinology，2021 Apr，12():641336 | 2021 . 04 |
| 9 | (Yung-Kai Huang)、曾國峰(Tseng, Guo-Fong)、蔡秉宣(TSAI, PING-HSUAN)、王捷賢(Jie-Sian Wang)、(Chang-Yu Lee)、沈明毅(Ming-Yi Shen)*，IL-8 as a Potential Therapeutic Target for Periodontitis and Its Inhibition by Caffeic Acid Phenethyl Ester In Vitro，INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES，2021 Mar，22():3641 | 2021 . 03 |
| 10 | (Chih-Wei Hsia)、(Ming-Ping Wu)、沈明毅(Ming-Yi Shen)、(Chih-Hsuan Hsia)、(Chi-Li Chung)、(Joen-Rong Sheu)*，Regulation of Human Platelet Activation and Prevention of Arterial Thrombosis in Mice by Auraptene through Inhibition of NF-κB Pathway，INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES，2020 Jul，21():4810-4824 | 2020 . 07 |
| 11 | 王捷賢(Jie-Sian Wang)、(Wei-Shan Chen)、林橙莉(Cheng-Li Lin)、王怡寬(I-Kuan Wang)、沈明毅(Ming-Yi Shen)*，Risk of Carpal Tunnel Syndrome after Parathyroidectomy in Patients with End-Stage Renal Disease: A Population-Based Cohort Study in Taiwan.，MEDICINE，2020 Apr，(): | 2020 . 04 |
| 12 | 王駿丞(Chun-Cheng Wang)、李安生(An-Sheng Lee)、劉淑惠(LIU SHU-HUI)、張坤正(Kuan-Cheng Chang)、沈明毅(Ming-Yi Shen)、張志宗(Chiz-Tzung Chang)*，Spironolactone ameliorates endothelial dysfunction through inhibition of the AGE/ RAGE axis in a chronic renal failure rat model，BMC Nephrology，2019 Sep，20(1):351 | 2019 . 09 |
| 13 | 沈明毅(Ming-Yi Shen)、(Jing-Fang Hsu)、(Fang-Yu Chen)、(Jonathan Lu)、(Chia-Ming Chang)、(Mohammad Madjid)、(Juliette Dean)、(Richard A.F. Dixon)、(Steven Shayani)、周子傑*、(Chu-Huang Chen)，Combined LDL and VLDL Electronegativity Correlates with Coronary Heart Disease Risk in Asymptomatic Individuals，Journal of Clinical Medicine，2019 Aug，(): | 2019 . 08 |
| 14 | 王駿丞(Chun-Cheng Wang)、沈明毅(Ming-Yi Shen)、張坤正(Kuan-Cheng Chang)、汪貴珍(Guei-Jane Wang)、劉淑惠(LIU SHU-HUI)、張志宗(Chiz-Tzung Chang)*，Skin autofluorescence is associated with rapid renal function decline in subjects at increased risk of coronary artery disease，PLoS One，2019 May，14(5):e0217203 | 2019 . 05 |
| 15 | (Chun-Yu Chang)、(Chu-Huang Chen)、(Yi-Ming Chen)、(Tsu-Yi Hsieh)、(Ju-Pi Li)、沈明毅(Ming-Yi Shen)、藍忠亮(Joung-Liang Lan)*、陳得源(Der-Yuan Chen)*，Association between Negatively Charged Low-Density Lipoprotein L5 and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients.，Journal of Clinical Medicine，2019 Feb，8(2):1-14 | 2019 . 02 |
| 16 | 張志宗(Chiz-Tzung Chang)、沈明毅(Ming-Yi Shen)、謝如怡、張家銘(Chia-Ming Chang)、廖欣儀(Hsin-Yi Liao)、陳芳玉、許重義(Chung Y. Hsu)、楊朝諭、陳朝榮(Chao-Jung Chen)*，Increased electronegativity of high-density lipoprotein in uremia patients impairs its functional properties and is associated with the risk of coronary artery disease，ATHEROSCLEROSIS，2018 Nov，278():147-155 | 2018 . 11 |
| 17 | 周安國(Chou, An-Kuo)、沈明毅(Shen, Ming-Yi)、陳芳玉(Chen, Fang-Yu)、蕭捷倫(Chieh-Lun Hsiao)、施亮均(Liang-Chun Shih)、張文馨(Chang, Wen-Shin)、蔡佳紋(Tsai, Chia-Wen)、(TSUNG-HO YING)、(MING-HSIEN WU)、(CHUN-YU HUANG)、包大靝(Bau, Da-Tian)*，The Association of Flap Endonuclease 1 Genotypes with the Susceptibility of Endometriosis，Cancer Genomics & Proteomics，2017 Sep，(): | 2017 . 09 |
| 18 | 張志宗(Chiz-Tzung Chang)、沈明毅(Ming-Yi Shen)、李安生(An-Sean Lee)、王駿丞(Chun-Cheng Wang)、陳威宇(Chen, Wei-Yu)、張家銘(Chia-Ming Chang)、張坤正(Kuan-Cheng Chang)、(Nicole Stancel)、陳珠璜(Chu-Huang Chen)*，Electronegative low-density lipoprotein increases the risk of ischemic lower-extremity peripheral artery disease in uremia patients on maintenance hemodialysis，Scientific Reports，2017 Jul，7(1):4654 | 2017 . 07 |
| 19 | (YI-WEN HUNG)、蔡佳紋(Tsai, Chia-Wen)、(CHENG-NAN WU)、施亮均(Liang-Chun Shih)、陳妍宇(Yan-Yu Chen)、劉彥芳(Yen-Fang Liu)、洪慧珊(Huey-Shan Hung)、沈明毅(Ming-Yi Shen)、張文馨(Chang, Wen-Shin)、包大靝(Da-Tian Bau)*，The Contribution of Matrix Metalloproteinase-8 Promoter Polymorphism to Oral Cancer Susceptibility，IN VIVO，2017 Jul，31(4):585-590 | 2017 . 07 |
| 20 | 王駿丞(Chun-Cheng Wang)、(Yao-Chang Wang)、汪貴珍(Guei-Jane Wang)、沈明毅(Ming-Yi Shen)、(Yen-Lin Chang)、(Show-Yih Liou)、陳虹志(Hung-Chih Chen)、李安生(An-Sheng Lee)、張坤正(Kuan-Cheng Chang)、陳威宇(Chen, Wei-Yu)、張志宗(Chiz-Tzung Chang)*，Skin autofluorescence is associated with inappropriate left ventricular mass and diastolic dysfunction in subjects at risk for cardiovascular disease，Cardiovascular Diabetology，2017 Jan，16(1): | 2017 . 01 |
| 21 | 張志宗(Chang, Chiz-Tzung)、汪貴珍(Wang, Guei-Jane)、郭錦輯(Kuo, Chin-Chi)、謝如怡(Hsieh, Ju-Yi)、李安生(An-Sheng Lee)、張家銘(Chia-Ming Chang)、王駿丞(Chun-Cheng Wang)、沈明毅(Shen, Ming-Yi)、黃秋錦(Huang, Chiu-Ching)、(Tatsuya Sawamura)、(Chao-Yuh Yang)、(Nicole Stancel)、陳珠磺(Chu-Huang Chen)*，Electronegative Low-density Lipoprotein increases coronary artery disease risk in uremia patients on maintenance hemodialysis，MEDICINE，2016 Nov，95(2):e2265 | 2016 . 11 |
| 22 | 沈明毅(Ming-Yi Shen)、陳芳玉(Fang-Yu Chen)、許菁芳(Jing-Fang Hsu)、傅如輝(Ru-Huei Fu)、張家銘(Chia-Ming Chang)、張志宗(Chiz-Tzung Chang)、劉崇祥(Chung-Hsiang Liu)、吳佳蓉(Wu,Jia-Rong)、李安生(An-Sheng Lee)、(Hua-Chen Chan)、(Joen-Rong Sheu)、林欣榮(Shinn-Zong Lin)、徐偉成(Woei-Cherng Shyu)、(Tatsuya Sawamura)、張坤正(Kuan-Cheng Chang)、許重義(Chung Y. Hsu)*、(Chu-Huang Chen)*，Plasma L5 levels are elevated in ischemic stroke patients and enhance platelet aggregation，BLOOD，2016 Mar，127(10):1336-1345 | 2016 . 03 |
| 23 | 王駿丞(Chun-Cheng Wang)、王耀章(Wang, Yao-Chang)、汪貴珍(Wang, Guei-Jane)、沈明毅(Shen, Ming-Yi)、張炎林(Chang, Yen-Lin)、劉紹毅(Liou, Show-Yih)、陳虹志(Hung-Chih Chen)、張志宗(Chang, Chiz-Tzung)*，Skin autofluorescence is associated with endothelial dysfuntion in uremic subjects on hemodialysis，PLoS One，2016 Jan，11(1):e0147771 | 2016 . 01 |
| 24 | (LM Lien)、(Wang MJ)、(Chen RJ)、Chiu HC、(Wu JL)、沈明毅(Ming-Yi Shen)、(Sheu JR)、(Lin KH)、劉興華(Shibg-Hwa Liu)*，Nobiletin, a Polymethoxylated Flavone, Inhibits Glioma Cell Growth and Migration via Arresting Cell Cycle and Suppressing MAPK and Akt Pathways.，PHYTOTHERAPY RESEARCH，2015 Oct，(): | 2015 . 10 |
| 25 | 紀宏學(HONG-XUE JI)、張文馨(WEN-SHIN CHANG)、蔡佳紋(CHIA-WEN TSAI)、(JU-YU WANG)、(NAI-KUEI HUANG)、(AN-SHENG LEE)、沈明毅(Ming-Yi Shen)、(WEI-YU CHEN)、江耀璋(Yao-Chang Chiang)、施子卿(TZU-CHING SHIH)*、(CHIN-MU HSU)*、包大靝(Da-Tian Bau)*，Contribution of DNA Repair Xeroderma Pigmentosum Group D Genotype to Gastric Cancer Risk in Taiwan，ANTICANCER RESEARCH，2015 Aug，35(8):4975-4982 | 2015 . 08 |
| 26 | 陳威宇(Wei-Yu Chen)、陳芳玉(Fang-Yu Chen)、李安生(An-Sheng Lee)、丁冠翔(Kuan-Hsiang Ting)、張家銘(Chia-Ming Chang)、許菁芳(Jing-Fang Hsu)、(Wei-Shine Lee)、(Joen-Rong Sheu)、(Chu-Huang Chen)*、沈明毅(Ming-Yi Shen)*，Sesamol Reduces the Atherogenicity of Electronegative L5 LDL in Vivo and in Vitro，JOURNAL OF NATURAL PRODUCTS，2015 Feb，78():225-233 | 2015 . 02 |
| 27 | 李安生(An-Sheng Lee)、陳威宇(Wei-Yu Chen)、詹華蓁(Hua-Chen Chan)、許菁芳(Jing-Fang Hsu)、沈明毅(Ming-Yi Shen)、張家銘(Chia-Ming Chang)、(Henry Bair)、(Ming-Jai Su)、張坤正(Kuan-Cheng Chang)*、陳珠璜(Chu-Huang Chen)*，Gender disparity in LDL-induced cardiovascular damage and the protective role of estrogens against electronegative LDL，Cardiovascular Diabetology，2014 Mar，13(64): | 2014 . 03 |
| 28 | 謝如怡(Ju-Yi Hsieh)、張志宗(Chiz-Tzung Chang)、(Max T. Huang)、張家銘(Chia-Ming Chang)、陳佳瑩(Chia-Ying Chen)、沈明毅(Ming-Yi Shen)、廖欣儀(Hsin-Yi Liao)、汪貴珍(Guei-Jane Wang)、陳珠璜(Chu-Huang Chen)*、陳朝榮(Chao-Jung Chen)*、楊朝諭(Chao-yuh Yang)*，Biochemical and Functional Characterization of Charge-defined Subfractions of High-density Lipoprotein From Normal Adults，ANALYTICAL CHEMISTRY，2013 Dec，85(23):11440-11448 | 2013 . 12 |
| 29 | 詹華蓁(Hua-Chen Chan)、(Ke LY)、(Chu CS)、李安生(An-Sheng Lee)、沈明毅(Ming-Yi Shen)、(Cruz MA)、(Hsu JF)、(Cheng KH)、(Chan HB)、(Lu J)、(Lai WT)、(Sawamura T)、(Sheu SH)、(Yen JH)、陳珠璜(Chu-Huang Chen)*，Highly electronegative LDL from patients with ST-elevation myocardial infarction triggers platelet activation and aggregation，BLOOD，2013 Sep，--(): | 2013 . 09 |
| 30 | (Cicero Lee-Tian Chang,)、(Hsien-Yueh Liu,)、(Tien-Fen Kuo)、(Yi-Jou Hsu)、沈明毅(Ming-Yi Shen)、(Chien-Yuan Pan)、(Wen-Chin Yang)*，Antidiabetic effect and mode of action of cytoplioyne，Evidence-based Complementary and Alternative Medicine，2013 Mar，2013(685642):1-13 | 2013 . 03 |
| 31 | 沈明毅(Ming-Yi Shen)、(Wen-Chin Yang)*，Catenarin prevents type 1 diabetes in non-obese diabetic mice via inhibition of leukocyte migration involving the MEK6/p38 and MEK7/JNK pathway，Evidence-based Complementary and Alternative Medicine，2012 ，(): | 2012 . |
| 32 | 沈明毅(Ming-Yi Shen)、(Yea-Lih Lin)、(Wen-Chin Yang)*，Combined phytochemistry and chemotaxis assays for identification and mechanistic analysis of anti-inflammatory phytochemicals in Fallopia japonica，PLoS One，2011 Nov，6(11):e27480-e27480 | 2011 . 11 |
| 33 | (Ming Jen Hsu)、(Joen Rong Sheu)、(Chien Huang Lin)、沈明毅(Ming-Yi Shen)、許重義(Chung Y. Hsu)*，Mitochondrial mechanisms in amyloid beta peptide-induce cerebrovascular degeneration，BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS，2010 Mar，1800(3):290-296 | 2010 . 03 |
| 34 | 沈明毅(Ming-Yi Shen)、許準榕(Sheu JR)*，Expression of amyloid beta peptide in human platelets: pivotal role of the phospholipase Cgamma2-protein kinase C pathway in platelet activation，PHARMACOLOGICAL RESEARCH，2008 ，57(-):151-158 | 2008 . |
| 35 | 沈明毅(Ming-Yi Shen)、許準榕(Sheu JR)*、許重義(Chung Y. Hsu)，Amyloid beta peptide-activated signal pathways in human platelets，European Journal of Pharmacology，2008 ，588(-):259-266 | 2008 . |
| 36 | 沈明毅(Ming-Yi Shen)、(Sheu JR)*，Involvement of p38 MAPK phosphorylation and nitrate formation in aristolochic acid-mediated antiplatelet activity，PLANTA MEDICA，2008 ，74(-):1240-1245 | 2008 . |
| 37 | 沈明毅(Ming-Yi Shen)、(Sheu JR)*，Inhibitory mechanisms of resveratrol in platelet activation: pivotal roles of p38 MAPK and NO/cyclic GMP，BRITISH JOURNAL OF HAEMATOLOGY，2007 ，139(-):475-485 | 2007 . |
| 38 | 沈明毅(Ming-Yi Shen)、(Sheu JR)*，Neuroprotective effects of PMC, a potent alpha-tocopherol derivative, in brain ischemia-reperfusion: reduced neutrophil activation and anti-oxidant actions，BIOCHEMICAL PHARMACOLOGY，2007 ，73(5):682-693 | 2007 . |
| 39 | 沈明毅(Ming-Yi Shen)、(Sheu JR)*，Inhibitory mechanisms of gabapentin, an antiseizure drug, on platelet aggregation，JOURNAL OF PHARMACY AND PHARMACOLOGY，2007 ，59(-):1255-1261 | 2007 . |
| 40 | 沈明毅(Ming-Yi Shen)、(Sheu JR)*，Inhibitory mechanisms of activated matrix metalloproteinase-9 on platelet activation，European Journal of Pharmacology，2006 ，537(1-3):52-58 | 2006 . |
| 41 | 沈明毅(Ming-Yi Shen)、(Sheu JR)*，Inhibitory mechanisms of low concentrations of oxidized low-density lipoprotein on platelet aggregation，JOURNAL OF BIOMEDICAL SCIENCE，2006 ，13(-):333-343 | 2006 . |
| 42 | 沈明毅(Ming-Yi Shen)、(Sheu JR)*，Inhibitory effects of lycopene on in vitro platelet activation and in vivo prevention of thrombus formation，JOURNAL OF LABORATORY AND CLINICAL MEDICINE，2005 ，146(4):216-226 | 2005 . |
| 43 | 沈明毅(Ming-Yi Shen)、(Sheu JR)*，ESR spin trapping of a carbon-centered free radical from agonist-stimulated human platelets，FREE RADICAL BIOLOGY AND MEDICINE，2005 ，39(2):237-248 | 2005 . |
| 44 | 沈明毅(Ming-Yi Shen)、(Sheu JR)，C-phycocyanin, a very potent and novel platelet aggregation inhibitor from Spirulina platensis，JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY，2005 ，53(20):7734-7740 | 2005 . |
| 45 | 沈明毅(Ming-Yi Shen)、(Sheu JR)*，alpha-Naphthoflavone, a potent antiplatelet flavonoid, is mediated through inhibition of phospholipase C activity and stimulation of cyclic GMP formation，JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY，2005 ，53(13):5179-5186 | 2005 . |
| 46 | 沈明毅(Ming-Yi Shen)、(Sheu JR)*，Inhibitory mechanisms of YC-1 and PMC in the induction of iNOS expression by lipoteichoic acid in RAW 264.7 macrophages，BIOCHEMICAL PHARMACOLOGY，2004 ，67(7):1411-1419 | 2004 . |
| 47 | (Sheu JR)*、沈明毅(Ming-Yi Shen)，Mechanisms involved in the antiplatelet activity of rutin, a glycoside of the flavonol quercetin, in human platelets.，JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY，2004 ，52(14):4414-4418 | 2004 . |
| 48 | 沈明毅(Ming-Yi Shen)、(Sheu JR)*，Involvement of the antiplatelet activity of magnesium sulfate in suppression of protein kinase C and the Na+/H+ exchanger，JOURNAL OF BIOMEDICAL SCIENCE，2004 ，11(6):19-26 | 2004 . |
| 49 | 沈明毅(Ming-Yi Shen)、(Sheu JR)*，Low concentration of oxidized low density lipoprotein suppresses platelet reactivity in vitro: an intracellular study，LIPIDS，2004 ，39(5):433-440 | 2004 . |
| 50 | 沈明毅(Ming-Yi Shen)、(Sheu JR)*，Mechanisms involved in the antiplatelet activity of ketamine in human platelets，JOURNAL OF BIOMEDICAL SCIENCE，2004 ，11(6):764-772 | 2004 . |
| 51 | (Sheu JR)*、沈明毅(Ming-Yi Shen)，Expression of matrix metalloproteinase-9 in human platelets: regulation of platelet activation in in vitro and in vivo studies，BRITISH JOURNAL OF PHARMACOLOGY，2004 ，143(1):193-201 | 2004 . |
| 52 | 沈明毅(Ming-Yi Shen)、(Sheu JR)*，Mechanisms of antiplatelet and antithrombotic activity of midazolam in in vitro and in vivo studies，European Journal of Pharmacology，2004 ，487(1-3):159-166 | 2004 . |
| 53 | 沈明毅(Ming-Yi Shen)、(Sheu JR)*，Antioxidative and hepatoprotective effects of Antrodia camphorata extract，JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY，2003 Apr，51(11):3302-3308 | 2003 . 04 |
| 54 | 沈明毅(Ming-Yi Shen)，Inhibitory activity of kinetin on free radical formation of activated platelets in vitro and on thrombus formation in vivo，European Journal of Pharmacology，2003 Feb，465(3):281-287 | 2003 . 02 |
| 55 | (Sheu JR)*、沈明毅(Ming-Yi Shen)，Antithrombotic effects of magnesium sulfate in in vivo experiments，INTERNATIONAL JOURNAL OF HEMATOLOGY，2003 ，77(4):414-419 | 2003 . |
| 56 | (Sheu JR)、沈明毅(Ming-Yi Shen)，Inhibitory mechanisms of kinetin, a plant growth-promoting hormone, in platelet aggregation，PLATELETS，2003 ，14(3):189-196 | 2003 . |
| 57 | Sheu JR*、沈明毅(Ming-Yi Shen)，Inhibitory mechanisms of metallothionein on platelet aggregation in in vitro and platelet plug formation in in vivo experiments，EXPERIMENTAL BIOLOGY AND MEDICINE，2003 ，228(11):1321-1328 | 2003 . |
| 58 | 沈明毅(Ming-Yi Shen)、(Sheu JR)*，Morphine-potentiated platelet aggregation in in vitro and platelet plug formation in in vivo experiments，JOURNAL OF BIOMEDICAL SCIENCE，2003 ，10(3):292-301 | 2003 . |
| 59 | 沈明毅(Ming-Yi Shen)，A novel antioxidant, octyl caffeate, suppression of LPS/IFN- gamma- induced inducible nitric oxide synthase gene expression in rat aortic smooth muscle cells，BIOCHEMICAL PHARMACOLOGY，2003 ，65(8):1383-1392 | 2003 . |
| 60 | 沈明毅(Ming-Yi Shen)、(Sheu JR)*，Platonin, a photosensitizing dye, improves circulatory failure and mortality in rat models of endotoxemia，BIOLOGICAL & PHARMACEUTICAL BULLETIN，2002 Aug，25(8):995-999 | 2002 . 08 |
| 61 | (Sheu JR)*、沈明毅(Ming-Yi Shen)，Mechanisms involved in the antiplatelet activity of magnesium in human platelets，BRITISH JOURNAL OF HAEMATOLOGY，2002 ，119():1033-1041 | 2002 . |
| 62 | (Sheu JR)*、沈明毅(Ming-Yi Shen)，The hyperaggregability of platelets from normal pregnancy is mediated through thromboxane A2 and cyclic AMP pathways.，CLINICAL AND LABORATORY HAEMATOLOGY，2002 ，24(2):121-129 | 2002 . |
研討會論文
|
研討會論文／Conference Papers (發表主題或論文名稱，研討會名稱，演講地點，研討會期間，受邀演講題目) |
日期 | |
| 1 | Kansuinine A Increases Insulin Secretion in Rin-m5f Cells by Inhibiting Apolipoprotein C3 Rich Low-density Lipoprotein -Induced Upregulation of LOX-1 Receptor，39th SNP and 24th SFRR-Taiwan，Taoyuan, Taiwan，2024.10.04~2024.10.06， | 2024 . 10 |
| 2 | Fenamic acid derivatives reduce cardiovascular disease in patients with diabetes，82ND FIP World Congress of Pharmacy and Pharmaceutical Sciences 2024，Cape Town, South Africa，2024.09.01~2024.09.04， | 2024 . 09 |
| 3 | Apolipoprotein C3-rich low-density lipoprotein (AC3RL) exacerbates cerebral ischaemic stroke injury by increasing BBB leakage via LOX-1，ESC Congress 2024，London - United Kingdom，2024.08.30~2024.09.02， | 2024 . 08 |
| 4 | AC3RL Facilitates Platelets Aggregation Through Activating VWF Secretion and ROS Generation of Platelets to Promote Thrombosis，38th Joint Annual Conference of Biomedical Science，Taipei, Taiwan，2024.03.23~2024.03.24， | 2024 . 03 |
| 5 | The Mechanism of AC3R-induced Post ischemic Damage with the Involvement of Oxidative Stress Derived from NADPH Oxidase，The 38th Joint Annual Conference of Biomedical Science，Taipei, Taiwan，2024.03.23~2024.03.24， | 2024 . 03 |
| 6 | Kansuinine A protects Apolipoprotein C3 Rich Low-Density Lipoprotein‐induced RIN‐m5F β‐cell Apoptosis through Reactive Oxygen Species Signals，The 38th Joint Annual Conference of Biomedical Science，Taipei, Taiwan，2024.03.23~2024.03.24， | 2024 . 03 |
| 7 | Apolipoprotein C3-Rich Low-Density Lipoprotein Induces Endothelial Cell Senescence via FBXO31 and Its Inhibition by Sesamol In Vitro and In Vivo，The 38th Joint Annual Conference of Biomedical Science，Taipei, Taiwan，2024.03.23~2024.03.24， | 2024 . 03 |
| 8 | Acetic Acids Derivatives Inhibits Apolipoprotein C3-Rich Low-density Lipoprotein-Induced Apoptosis in Endothelial Cells，IDF Virtual Congress 2023，On line，2023.12.04~2023.12.07， | 2023 . 12 |
| 9 | Apolipoprotein C3-Rich Low-Density Lipoprotein (LDL) Induces Human Aortic Endothelial Cells Senescence via FBXO31/p53/p21，Kidney Week 2023，Philadelphia, PA，2023.11.02~2023.11.05， | 2023 . 11 |
| 10 | Propionic acid derivatives ameliorate the risk of acute coronary syndrome in patients with dyslipidemia，2023 29th FAPA Congress，Taipei, Taiwan，2023.10.24~2023.10.28， | 2023 . 10 |
| 11 | Propionic acid derivatives improve cardiovascular disease in patients with diabetes，81st FIP World Congress of Pharmacy and Pharmaceutical Sciences 2023，Brisbane, Qld, Australia，2023.09.24~2023.09.28， | 2023 . 09 |
| 12 | Apolipoprotein C3-rich low-density lipoprotein (AC3RL) increases BBB permeability and worsens cerebral ischemic stroke injury，ESC Congress 2023，Amsterdam, Netherlands，2023.08.25~2023.08.28， | 2023 . 08 |
| 13 | Sesamol alleviates renal injury and arrests reactive oxygen species-induced IKKα signaling in macrophages，19th World Congress of Basic & Clinical Pharmacology 2023，Glasgow, Scotland，2023.07.02~2023.07.07， | 2023 . 07 |
| 14 | Apolipoprotein C3-Rich Low-Density Lipoprotein Promotes ADP-Induced Platelet Activation and Its Inhibition by Kansuinine A，2023 The 37th Joint Annual Conference of Biomedical Science，Taipei, Taiwan，2023.03.18~2023.03.19， | 2023 . 03 |
| 15 | Apolipoprotein C3-Rich Low-Density Lipoprotein Induces Endothelial Cell Senescence via Oxidative Stress/FBXO31/p53，2022台灣腎臟醫學會111年度會員大會暨學術演講會，南港展覽館2館7樓，2022.12.10~2022.12.11， | 2022 . 12 |
| 16 | Acetic acid derivatives Ameliorate Atherosclerosis in Streptozotocin-induced Diabetic Mice by Cyclooxygenase-2，IDF World Diabetes Congress 2022，Lisbon, Portugal and online，2022.12.05~2022.12.08， | 2022 . 12 |
| 17 | Effects of acetic acid derivatives on stroke risk in patients with diabetes mellitus，IDF World Diabetes Congress 2022，Lisbon, Portugal and online，2022.12.05~2022.12.08， | 2022 . 12 |
| 18 | Acetic acid derivatives improve cardiovascular disease in patients with dyslipidemia.，28th The Federation of Asian Pharmaceutical Associations (FAPA) Congress 2022，Kuala Lumpur, Malaysia，2022.11.08~2022.11.12， | 2022 . 11 |
| 19 | Kansuinine A inhibits apolipoprotein C3 rich low-density lipoprotein induced apoptosis in islet β cells via IKK.，The 37th Symposium on Natural Products & the Ceremony in Honor of Late Academician Professor Kuo-Hsiung Lee，Kaohsiung, Taiwan，2022.10.21~2022.10.23， | 2022 . 10 |
| 20 | Study for the Mechanism of Kansuinine A Inhibit Apolipoprotein C3-Rich Low-Density Lipoprotein-Induced β-cell Apoptosis，The 36th Joint Annual Conference of Biomedical Sciences，Taipei, Taiwan，2022.03.26~2022.03.27， | 2022 . 03 |
| 21 | Exosomes regulate switch from M1 to M2 macrophages to reduce kidney inflammation in 5/6Nx mice，2022 The 36th Joint Annual Conference of Biomedical Science，Taipei, Taiwan，2022.03.26~2022.03.27， | 2022 . 03 |
| 22 | Sesamol Ameliorates Renal Injury-Mediated Atherosclerosis Via Inhibition of Oxidative Stress/IKKα/p53，5th Congress of Asian Pacific Society of Dialysis Access in conjunction with 2021 Annual Meeting of Taiwan Society of Nephrology，Kaohsiung Exhibition Center, Kaohsiung, Taiwan，2021.12.10~2021.12.12， | 2021 . 12 |
| 23 | Acetic acid derivatives reduce the risk of acute coronary syndrome in patients with diabetes mellitus.，IDF Virtual Congress 2021，Virtual 網路視訊，2021.12.6 ~2021.12.11， | 2021 . 12 |
| 24 | Diclofenac sodium Reduces endothelial cell senescence induced by Apolipoprotein C3-rich LDL，14th Meeting of the Asia Pacific Federation of Pharmacologists，Taipei, Taiwan，2021.11.26~2021.11.29， | 2021 . 11 |
| 25 | Apolipoprotein C3 rich LDL is elevated in diabetic kidney disease patients and enhance endothelial cell injury.，JASN Kidney Week 2021，San Diego, CA, USA. and Virtual，2021.11.2 ~2021.11.7 ， | 2021 . 11 |
| 26 | Sesamol Endeavored to Decrease Apolipoprotein C3-Rich LDL-Induced Cerebral Ischemia-Reperfusion Injury.，14th Meeting of the Asia Pacific Federation of Pharmacologists (APFP2021)，Taipei, Taiwan，2021.11.26~2021.11.29， | 2021 . 11 |
| 27 | Kansuinine A inhibits platelet activation and aggregation via NF-κB pathway，The 36th Symposium on Natural Products & Symposium on Pharmacy and Traditional Chinese Medicine，National Sun Yat-sen University, Kaohsiung，2021.10.14~2021.10.16， | 2021 . 10 |
| 28 | Sesamol attenuates apolipoprotein C3 rich LDL-induced inflammation and improves renal function in 5/6 Nx mice，The 36th Symposium on Natural Products & Symposium on Pharmacy and Traditional Chinese Medicine，National Sun Yat-sen University, Kaohsiung，2021.10.14~2021.10.16， | 2021 . 10 |
| 29 | Caffeic acid phenethyl ester suppress IL-8 expression in THP-1 cell，The 35th Symposium of Natural Products，Taipei, Taiwan，2020.09.11~2020.09.13， | 2020 . 09 |
| 30 | Protective Effect of Kansuinine A Inhibits Hydrogen Peroxide-Induced Oxidative Stress In Vitro，The 35th Symposium of Natural Products，Taipei, Taiwan，2020.09.11~2020.09.13， | 2020 . 09 |
| 31 | Anti-apoptotic effects of Kansuinine A on human aortic endothelial cell，China Medical University and Asia University Joint Conference on Biotechnology，Taichung, Taiwan （線上直播），2020.05.12~2020.05.12， | 2020 . 05 |
| 32 | Kansuinine A Against Reactive Oxygen Species-Injury via IKK Pathway in Human Aortic Endothelial Cell，The 34th symposium of Natural Products，Taoyuan, Taiwan，2019.10.17~2019.10.19， | 2019 . 10 |
| 33 | Sesamol Protects Apolipoprotein C3-rich LDL-Induced Cell Damage and Cerebral Ischemia-Reperfusion Injury，The 34th symposium of Natural Products，Taoyuan, Taiwan，2019.10.17~2019.10.19， | 2019 . 10 |
| 34 | Apolipoprotein C3-rich LDL induces endothelial dysfunction and vascular cells senescence in Vivo，The 9th Federation of the Asia and Oceanian Physiological Societies Congress (FAOPS2019)，Kobe, Japan，2019.03.28~2019.03.31， | 2019 . 03 |
| 35 | RSV Reduces ROS-induced THP-1 Adhesion through PKCα Pathway，2019 The 34th Joint Annual Conference of Biomedical Sciences，Taipei, Taiwan，2019.03.23~2019.03.24， | 2019 . 03 |
| 36 | L5-induced oxidative stress cause HAECs apoptosis via IKK pathway，2019 The 34th Joint Annual Conference of Biomedical Sciences，Taipei, Taiwan，2019.03.23~2019.03.24， | 2019 . 03 |
| 37 | Silencing FBXO31 Reduces Apolipoprotein CIII-Rich Low-Density Lipoprotein-induced Endothelial Cell Senescence，2019 The 34th Joint Annual Conference of Biomedical Sciences，Taipei, Taiwan，2019.03.23~2019.03.24， | 2019 . 03 |
| 38 | AXRL is highly associated with atherosclerosis-related disease，2018 Taiwan Proteomics Society Annual Conference，Taichung, Taiwan，2018.11.17~2018.11.17， | 2018 . 11 |
| 39 | Sesamol Reduces the Senescence Induced by Apolipoprotein C3-rich LDL in Vivo and in Vitro.，The 33th Symposium on Natural Products，Kaohsiung, Taiwan，2018.10.06~2018.10.07， | 2018 . 10 |
| 40 | The study of biochemical and functional characterization of electronegative subfractions of high-density lipoprotein from patients with Type 2 Diabetes，33屆生物醫學聯合學術年會，Taipei, Taiwan，2018.03.24~2018.03.25， | 2018 . 03 |
| 41 | The Association of Flap Endonuclease 1 Genotypes with the Susceptibility of Endometriosis，33屆生物醫學聯合學術年會，國防醫學院，2018.03.24~2018.03.25， | 2018 . 03 |
| 42 | Sesamol protects against oxidative stress injury of atherogenic L5 via Stat3-HIF-1α-p53，33屆生物醫學聯合學術年會，Taipei, Taiwan，2018.03.24~2018.03.25， | 2018 . 03 |
| 43 | The Contribution of Matrix Metalloproteinase-8 Promoter Polymorphism to Oral Cancer Susceptibility，33屆生物醫學聯合學術年會，國防醫學院，2018.03.24~2018.03.25， | 2018 . 03 |
| 44 | Silencing ATG16L1 Prevents Potentiating Effects of Atherogenic Low-Density Lipoprotein L5 on Secretion of Von Willebrand factor，XXIII World Congress of Neurology，Kyoto, Japan.，2017.09.16~2017.09.21， | 2017 . 09 |
| 45 | Increased Electronegativity of High-density Lipoprotein in Uremia Patients Impairs its Functional Properties and Increases the Risk of Coronary Artery Disease，2017HUPO，都柏林，2017.09.17~2017.09.21， | 2017 . 09 |
| 46 | miR-145 and proatherogenic low-density lipoprotein are associated with the pathogenesis of acute ischemic stroke，28th Symposium on Cerebral Blood Flow, Metabolism and Function 13th Conference on Quantification of Brain Function with PET，Berlin, Germany.，2017.04.01~2017.04.04， | 2017 . 04 |
| 47 | Atherogenic LDL-Induced Endothelial Cell Senescence Via FBXO31.，第32屆生物醫學聯合學術年會，Taipei, Taiwan，2017.03.25~2017.03.26， | 2017 . 03 |
| 48 | Sesamol modulates atherogenic L5-induced cell apoptotic signaling in vivo and in vitro，第31屆天然藥物研討會藥學暨中醫藥學門成果發表會，Kaohsiung, Taiwan，2016.10.14~2016.10.15， | 2016 . 10 |
| 49 | Antagomir-145 suppresses atherogenic low-density lipoprotein (l5)-enhanced platelet activation and ischemic stroke mediated by amyloid β，ASIA PACIFIC STROKE CONFERENCE，Brisbane, Qld, Australia，2016.07.15~2016.07.17， | 2016 . 07 |
| 50 | The discovery of HDL-associated protein biomarkers to predict stroke，亞太平洋中風會議，布里斯本，2016.07.14~2016.07.17， | 2016 . 07 |
| 51 | The alteration of serum lipoprotein on profiles and physiological function among obstructive sleep apnea patients，ISEE-ISES AC2016，Sapporo, Japan，2016.06.26~2016.06.29， | 2016 . 06 |
| 52 | Sesamol inhibits atherogenic LDL-induced endothelial cell senescence in vivo and in vitro，The IUPHAR World Conference on the Pharmacology of Natural and Traditional Medicine 2015，Singapore，2015.07.22~2015.07.24， | 2015 . 07 |
| 53 | Sesamol against atherogenic LDL signaling through LOX-1 and reduces LDL electronegativity in Syrian hamsters，The 30th Joint Annual Conference of Biomedical Sciences，Taipei, Taiwan，2015.03.21~2015.03.22， | 2015 . 03 |
| 54 | Sesamol reduces LDL electronegativity in Syrian hamsters and blocks atherogenic L5 signaling through LOX-1，The WFAS World Acupuncture and Integrative Medicine Conference，Houston, Texas, USA，2014.10.31~2014.11.02， | 2014 . 10 |
| 55 | MiR-145 Strengthens Atherogenic Low-Density Lipoprotein-Induced Platelet Activation，第二十九屆生物醫學聯合學術年會，台北，台灣，2014.03.15~2014.03.16，MiR-145 Strengthens Atherogenic Low-Density Lipoprotein-Induced Platelet Activation | 2014 . 03 |
| 56 | Silencing miR-145 Prevents Potentiating Effects of Human Electronegative Low-Density Lipoprotein on Platelet Activation，American Heart Association Scientific Sessions 2013，Dallas, Texas, USA.，2013.11.16~2013.11.20， | 2013 . 11 |
| 57 | Electronegative Low-density Lipoprotein Induces Endothelial DNA Damage and Senescence in vivo，American Heart Association Scientific Session 2013，Dallas, TX, USA，2013.11.16~2013.11.20， | 2013 . 11 |
| 58 | Electronegative low-density lipoprotein induces endothelial DNA damage and senescence in vivo.，American Heart Association Scientific Sessions 2013，Dallas, Texas, USA，2013.11.16~2013.11.20， | 2013 . 11 |
| 59 | Electronegative LDL and Beta-Amyloid Synergistically Induced Platelet Activation that Can Be inhibited by Novel MicroRNA-145 and NF-κB Decoys，International Stroke Conference 2013，Honolulu,Hawaii, USA，2013.02.06~2013.02.08， | 2013 . 02 |
| 60 | Highly Electronegative LDL is Elevated in Patients With Acute Myocardial Infarction and Triggers Platelet Activation and Aggregation.，American Heart Association Scientific Sessions 2012，Los Angeles, California, USA，2012.11.03~2012.11.07， | 2012 . 11 |
| 61 | Catenarin inhibits CCR5 and CXCR4-mediated chemotaxis and autoimmune diabetes in non-obese diabetic mice.，14th International Congress of Immunology，Kobe, Japan，2010.08.22~2010.08.27， | 2010 . 08 |
專書
暫無資料研究計畫
|
研究計畫／Research Grant (研究類型，研究計畫代號，主持人，補助或委託單位名稱，計畫名稱，計畫期間) |
日期 | |
| 1 | 學生參與計畫，CMU113-SR-126，鄭傑文(CHENG, CHIEH-WEN)，本校(含附醫)，探討芝麻酚降低AC3RL所導致的血小板聚集以及血栓的作用機轉，2024.8.1~2025.2.28 | 2024 . 08 |
| 2 | 學生參與計畫，CMU113-SR-48，張宇嫻(Chang, Yu-Hsien)，本校(含附醫)，探討富含載脂蛋白Ｃ3之低密度脂蛋白引發NADPH oxidase 產生氧化壓力所致缺血性腦中風後腦損傷之機轉，2024.8.1~2025.2.28 | 2024 . 08 |
| 3 | 學生參與計畫，113-2813-C-039-050-B，張宇嫻(Chang, Yu-Hsien)，科技部，探討富含載脂蛋白Ｃ3之低密度脂蛋白引發NADPH oxidase 產生氧化壓力所致缺血性腦中風後腦損傷之機轉，2024.7.1~2025.2.28 | 2024 . 07 |
| 4 | 學生參與計畫，113-2813-C-039-128-B，鄭傑文，科技部，探討芝麻酚降低AC3RL所導致的血小板聚集以及血栓的作用機轉，2024.7.1~2025.2.28 | 2024 . 07 |
| 5 | 學生參與計畫，CMU112-SR-105，，本校(含附醫)，芝麻酚減緩缺血性腦中風後富含載脂蛋白C3之低密度脂蛋白所致腦損傷之效果與機轉，2023.8.1~2024.2.29 | 2023 . 08 |
| 6 | 學生參與計畫，112-2813-C-039-114-B，，科技部，芝麻酚減緩缺血性腦中風後富含載脂蛋白C3之低密度脂蛋白所致腦損傷之效果與機轉，2023.7.1~2024.2.29 | 2023 . 07 |
| 7 | 個別型，MOST 111-2320-B-039-026，張力天，科技部，內皮細胞衍生外囊泡與其傳遞微小核糖核酸調控血小板活化、血栓形成與腦中風在糖尿病血脂異常疾病：轉譯醫學研究與中草藥治療策略，2022.8.1~2023.7.31 | 2022 . 08 |
| 8 | 個別型，CMU111-MF-52，，本校(含附醫)，特殊來源微小核糖核酸調控血小板活化、血栓形成與腦中風之機轉研究，2022.8.22~2023.7.31 | 2022 . 08 |
| 9 | 個別型，DMR-112-136，張志宗(Chiz-Tzung Chang)，附醫院內計畫，ATG16L1調節L5誘導動脈粥樣栓塞疾病之轉譯醫學研究，2022.8.1~2023.7.31 | 2022 . 08 |
| 10 | 個別型，CMU110-MF-41，，本校(含附醫)，天然物抑制致粥狀動脈硬化脂蛋白所引發腦中風之機轉研究，2021.8.1~2022.7.31 | 2021 . 08 |
| 11 | 學生參與計畫，CMU110-SR-101，，本校(含附醫)，甘遂減緩活性氧化物 ROS 造成之動脈粥樣硬化新機轉研究，2021.8.1~2022.2.28 | 2021 . 08 |
| 12 | 個別型，DMR-111-039，沈明毅(Ming-Yi Shen)，附醫院內計畫，在慢性腎臟病患者動脈硬化進展中血小板因子4扮演的作用，2021.8.1~2022.7.31 | 2021 . 08 |
| 13 | 個別型，MOST 109-2314-B-002 -111 -MY2，沈明毅(Ming-Yi Shen)，科技部，探討血脂異常對CADASIL疾病之影響，2021.8.1~2022.7.31 | 2021 . 08 |
| 14 | 個別型，MOST 108-2320-B-039-034-MY3，張力天，科技部，富含載脂蛋白C3低密度脂蛋白影響血小板活化促進缺血性腦中風之轉譯醫學研究與中草藥治療，2021.8.1~2022.7.31 | 2021 . 08 |
| 15 | 個別型，DMR-111-149，張志宗(Chiz-Tzung Chang)，附醫院內計畫，創新型腦中風生物標誌研究：惡性脂蛋白調控血小板粒線體轉變之轉譯醫學研究，2021.8.1~2022.7.31 | 2021 . 08 |
| 16 | 學生參與計畫，110-2813-C-039-363-B，，科技部，甘遂減緩活性氧化物 ROS 造成之動脈粥樣硬化新機轉研究，2021.7.1~2022.2.28 | 2021 . 07 |
| 17 | 個別型，MOST 108-2320-B-039-034-MY3，張力天，科技部，富含載脂蛋白C3低密度脂蛋白影響血小板活化促進缺血性腦中風之轉譯醫學研究與中草藥治療，2020.8.1~2021.7.31 | 2020 . 08 |
| 18 | 個別型，DMR-110-144，張志宗(Chiz-Tzung Chang)，附醫院內計畫，致病性低密度脂蛋白富含載脂蛋白C3 誘發動脈粥狀硬化血管疾病之轉譯醫學研究，2020.8.1~2021.7.31 | 2020 . 08 |
| 19 | 個別型，CMU109-MF-70，，本校(含附醫)，Sesamol 阻止載脂蛋白C3低密度脂蛋白促進缺血性腦中風之轉譯醫學研究，2020.8.1~2021.7.31 | 2020 . 08 |
| 20 | 個別型，DMR-110-013，沈明毅(Ming-Yi Shen)，附醫院內計畫，開發新的液相層析-二次質譜方法以分析人類脂蛋白上所含的氧化磷脂質產物，2020.8.1~2021.7.31 | 2020 . 08 |
| 21 | 學生參與計畫，CMU109-SR-35，，本校(含附醫)，芝麻酚保護血脂異常引發中風腦損傷之動物模型機轉研究，2020.8.1~2021.2.28 | 2020 . 08 |
| 22 | 個別型，MOST 109-2314-B-002-111 -MY2，沈明毅(Ming-Yi Shen)，科技部，探討血脂異常對CADASIL疾病之影響，2020.8.1~2021.7.31 | 2020 . 08 |
| 23 | 個別型，DMR-110-035，沈明毅(Ming-Yi Shen)，附醫院內計畫，血脂異常對糖尿病腎病變的轉譯醫學研究，2020.8.1~2021.7.31 | 2020 . 08 |
| 24 | 學生參與計畫，109-2813-C-039-040-B，，科技部，芝麻酚保護血脂異常引發中風腦損傷之動物模型機轉研究，2020.7.1~2021.2.28 | 2020 . 07 |
| 25 | 個別型，CMU108-MF-24，，本校(含附醫)，富含載脂蛋白C3低密度脂蛋白影響血小板活化促進缺血性腦中風之轉譯醫學研究與中草藥治療-I，2019.9.9~2020.7.31 | 2019 . 09 |
| 26 | 個別型，MOST 108-2320-B-039-034-MY3，張力天，科技部，富含載脂蛋白C3低密度脂蛋白影響血小板活化促進缺血性腦中風之轉譯醫學研究與中草藥治療，2019.8.1~2020.7.31 | 2019 . 08 |
| 27 | 個別型，DMR-109-026，沈明毅(Ming-Yi Shen)，附醫院內計畫，以液相層析-二次質譜分析尿毒症病人脂蛋白上所含的氧化1-palmitoyl-2-arachidonoyl- phosphatidylcholine (PAPC)，2019.8.1~2020.7.31 | 2019 . 08 |
| 28 | 個別型，DMR-109-142，張志宗(Chiz-Tzung Chang)，附醫院內計畫，載脂蛋白C3低密度脂蛋白引發血管內皮細胞老化之轉譯醫學研究，2019.8.1~2020.7.31 | 2019 . 08 |
| 29 | 學生參與計畫，CMU108-SR-104，，本校(含附醫)，載脂蛋白 C3 引發血管內皮細胞老化機轉研究 與天然物治療-以大花咸豐草萃取物為例，2019.8.1~2020.2.28 | 2019 . 08 |
| 30 | 學生參與計畫，CMU108-SR-84，，本校(含附醫)，甘遂抑制由極陰電性低密度脂蛋白引起活性氧化物質ROS於動脈粥狀硬化機轉研究，2019.8.1~2020.2.28 | 2019 . 08 |
| 31 | 個別型，DMR-109-174，沈明毅(Ming-Yi Shen)，附醫院內計畫，短片段非轉譯核糖核酸調節缺氧足細胞的凋亡作用，2019.8.1~2020.6.30 | 2019 . 08 |
| 32 | 學生參與計畫，108-2813-C-039-131-B，，科技部，載脂蛋白 C3 引發血管內皮細胞老化機轉研究 與天然物治療-以大花咸豐草萃取物為例，2019.7.1~2020.2.28 | 2019 . 07 |
| 33 | 學生參與計畫，108-2813-C-039-111-B，，科技部，甘遂抑制由極陰電性低密度脂蛋白引起活性氧化物質ROS於動脈粥狀硬化機轉研究，2019.7.1~2020.2.28 | 2019 . 07 |
| 34 | 學生參與計畫，CMU107-SR-62，，本校(含附醫)，活性氧化物質ROS在極陰電性低密度脂蛋白引發動脈粥狀硬化之新機轉研究與天然物治療，2018.8.1~2019.2.28 | 2018 . 08 |
| 35 | 個別型，DMR-108-127，張志宗(Chiz-Tzung Chang)，附醫院內計畫，致病性低密度脂蛋白調節內皮細胞自噬在心血管疾病之轉譯醫學研究，2018.8.1~2019.7.31 | 2018 . 08 |
| 36 | 個別型，MOST 105-2628-B-039-002-MY3，張力天，科技部，微核醣核酸調節極陰電性低密度脂蛋白促進缺血性腦中風的轉譯醫學研究與中草藥治療(3/3)，2018.8.1~2019.7.31 | 2018 . 08 |
| 37 | 學生參與計畫，107-2813-C-039-260-B，，科技部，活性氧化物質ROS在極陰電性低密度脂蛋白引發動脈粥狀硬化之新機轉研究與天然物治療，2018.7.1~2019.2.28 | 2018 . 07 |
| 38 | 整合型項下子計畫(主持人)，BM10701010021，沈明毅(Shen, Ming-Yi)、陳朝榮(Chen, Chao-Jung)、湯頌君、胡朝榮、吳明修、卓夙航(Juo, Suh-Hang)，中研院，腦中風之生物標誌研發，2018.1.1~2018.12.31 | 2018 . 01 |
| 39 | 個別型，DMR-107-025，沈明毅(Shen, Ming-Yi)，附醫院內計畫，腎小管細胞內吞作用不良與系統性發炎疾病導致的蛋白尿之關連，2017.8.1~2018.7.31 | 2017 . 08 |
| 40 | 學生參與計畫，CMU106-SR-37，，本校(含附醫)，載脂蛋白C3在陰電性低密度脂蛋白引發血管老化中所扮演之角色與機轉研究，2017.8.1~2018.2.28 | 2017 . 08 |
| 41 | 個別型，DMR-107-122，張志宗(Chang, Chiz-Tzung)，附醫院內計畫，粒線體損傷在缺血性腦中風之轉譯醫學研究，2017.8.1~2018.7.31 | 2017 . 08 |
| 42 | 個別型，MOST 105-2628-B-039-002-MY3，張力天，科技部，微核醣核酸調節極陰電性低密度脂蛋白促進缺血性腦中風的轉譯醫學研究與中草藥治療(2/3)，2017.8.1~2018.7.31 | 2017 . 08 |
| 43 | 學生參與計畫，106-2813-C-039-037-B，，科技部，載脂蛋白C3在陰電性低密度脂蛋白引發血管老化中所扮演之角色與機轉研究，2017.7.1~2018.2.28 | 2017 . 07 |
| 44 | 整合型項下子計畫(主持人)，BM10601010036，陳朝榮(Chao-Jung Chen)、沈明毅(Ming-Yi Shen)、胡朝榮、湯頌君、吳明修、徐偉成(Woei-Cherng Shyu)，中研院，臺灣人體生物資料庫腦中風之生物標誌研發，2017.1.1~2017.12.31 | 2017 . 01 |
| 45 | 個別型，DMR-106-118，張志宗(Chiz-Tzung Chang)，附醫院內計畫，極陰電性低密度脂蛋白調節內皮細胞溫韋伯氏因子釋放在腦心血管疾病之轉譯醫學研究，2016.8.1~2017.7.31 | 2016 . 08 |
| 46 | 個別型，MOST 105-2628-B-039-002-MY3，，科技部，微核醣核酸調節極陰電性低密度脂蛋白促進缺血性腦中風的轉譯醫學研究與中草藥治療，2016.8.1~2019.7.31 | 2016 . 08 |
| 47 | 學生參與計畫，CMU105-SR-48，，本校(含附醫)，極陰電性低密度脂蛋白透過內皮細胞自噬引發動脈粥狀硬化之機轉探討，2016.8.1~2017.2.28 | 2016 . 08 |
| 48 | 學生參與計畫，105-2815-C-039-049-B，，科技部，極陰電性低密度脂蛋白透過內皮細胞自噬引發動脈粥狀硬化之機轉探討，2016.7.1~2017.2.28 | 2016 . 07 |
| 49 | 整合型項下子計畫(主持人)，BM10501010037，陳朝榮(Chao-Jung Chen)、沈明毅(Ming-Yi Shen)、胡朝榮、湯頌君、吳明修、徐偉成(Woei-Cherng Shyu)，中研院，臺灣人體生物資料庫腦中風之生物標誌研發，2016.1.1~2016.12.31 | 2016 . 01 |
| 50 | 學生參與計畫，CMU104-SR-26，，本校(含附醫)，研究天然物抑制極陰電性低密度脂蛋白促使早期動脈粥狀硬化之機轉-以芝麻酚為例，2015.8.1~2016.2.28 | 2015 . 08 |
| 51 | 個別型，DMR-105-082，張志宗(Chiz-Tzung Chang)，附醫院內計畫，極陰電性低密度脂蛋白在動脈粥狀硬化血管疾病之轉譯醫學研究，2015.8.1~2016.7.31 | 2015 . 08 |
| 52 | 學生參與計畫，104-2815-C-039-026-B，，科技部，研究天然物抑制極陰電性低密度脂蛋白促使早期動脈粥狀硬化之機轉-以芝麻酚為例，2015.7.1~2016.2.28 | 2015 . 07 |
| 53 | 整合型項下子計畫(主持人)，BM104010092，陳朝榮(Chao-Jung Chen)、沈明毅(Ming-Yi Shen)、卓夙航、胡朝榮、湯頌君、吳明修，，臺灣人體生物資料庫腦中風之生物標誌研發，2015.1.1~2015.12.31 | 2015 . 01 |
| 54 | 個別型，CMU103-N-08，李安生(An-Sheng Lee)，本校(含附醫)，探討血小板內粒線體損傷在腦中風發生過程中所扮演之角色，2014.11.1~2015.7.31 | 2014 . 11 |
| 55 | 整合型項下子計畫(主持人)，BM103010096，陳朝榮(Chao-Jung Chen)、沈明毅(Ming-Yi Shen)、卓夙航、胡朝榮、湯頌君，中研院，臺灣人體生物資料庫腦中風之生物標誌研發，2014.1.1~2014.12.31 | 2014 . 01 |
| 56 | 個別型，CMU102-N-02，李安生(An-Sheng Lee)，本校(含附醫)，探討負電性低密度脂蛋白與血小板抗藥性造成經皮冠狀動脈介入治療後血管再窄化之機轉，2013.10.1~2014.7.31 | 2013 . 10 |
| 57 | 個別型，NSC 102-2320-B-039-058，陳珠璜(Chu-Huang Chen)，科技部，評估極負電性低密度脂蛋白在腦血管疾病中的角色，2013.9.1~2014.7.31 | 2013 . 09 |
| 58 | 整合型項下子計畫(主持人)，BM102021169，陳珠璜(Chu-Huang Chen)、陳朝榮(Chao-Jung Chen)、沈明毅(Ming-Yi Shen)、李安生(An-Sheng Lee)、楊懷壹(Hwai-I Yang)、卓夙航、胡朝榮、湯訟君，中研院，臺灣人體生物資料庫腦中風之生物標誌研發，2013.3.26~2013.12.31 | 2013 . 03 |
| 59 | 個別型，DMR-102-091，陳珠璜(Chu-Huang Chen)，附醫院內計畫，探討冠狀動脈疾病中負電性低密度脂蛋白(L5)刺激血小板活化與凝集機轉，2012.8.1~2013.6.30 | 2012 . 08 |
專利技術
暫無資料獲獎事蹟
|
獲獎／Award (獲獎名稱，給獎單位，獲獎日期) |
日期 | |
| 1 | 李鎮源教授醫學研究青年學者獎，財團法人李鎮源教授學術基金會，2016.9.20 | 2016 . 09 |
| 2 | ATVB Travel Award for Young Investigators，American Heart Association’s Council on Arteriosclerosis, Thromb，2013.11.19 | 2013 . 11 |
